Connect Biopharma Holdings Limited Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Connect Biopharma Holdings Limited (CNTB) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of $4.26 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2024-09-05
CNY
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|
| 2023-06-30 | 21.02M CNY 6-K · filed 2023-09-12 | |
| 2022-12-31 | -1.25B CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | -833.56M CNY 6-K · filed 2023-09-12 | |
| 2021-12-31 | 737.15M CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | 1.03B CNY 6-K · filed 2022-09-13 | |
| 2020-12-31 | 754.53M CNY 20-F · filed 2023-04-11 | |
| 2019-12-31 | -93.99M CNY 20-F · filed 2022-03-31 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month as first filed | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month as first filed |
|---|---|---|---|---|
| 2024-06-30 | $4.26M 6-K · filed 2024-09-05 | |||
| 2023-12-31 | $26.98M 20-F · filed 2024-04-16 | |||
| 2023-06-30 | $2.81M 6-K · filed 2024-09-05 | $2.91M 6-K · filed 2023-09-12 | ||
| 2022-12-31 | -$187.85M 20-F · filed 2024-04-16 | -$179.71M 20-F · filed 2023-04-11 | ||
| 2022-06-30 | -$124.20M 6-K · filed 2022-09-13 | |||
| 2021-12-31 | $112.69M 20-F · filed 2024-04-16 | $115.62M 20-F · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |